Cardiac macrophages and apoptosis after myocardial infarction: Effects of central MR blockade

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 7, 2014, Pages R879-R887

  Rafatian, Naimeh ^a,b   Westcott, Katherine V ^a,b   White, Roselyn A ^a   Leenen, Frans H H ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Aldosterone; Brain; Cardiac remodeling; Cell death; Inflammation; Mineralocorticoid receptors

Indexed keywords

B7 ANTIGEN; CASPASE 3; CD163 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; EPLERENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE ENDDIASTOLIC PRESSURE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NICK END LABELING; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84907612321     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00075.2014     Document Type: Article

References (50)

1. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14: 1835-1842, 2008.
2. Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms. Circulation 128: 388-400, 2004.
3. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 21: 295-301, 2004.
4. Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010. Circulation 128: 2577-2584, 2013.
5. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226: 316-327, 1996.
6. Dayan V, Yannarelli G, Billia F, Filomeno P, Wang XH, Davies JE, Keating A. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 106: 1299-1310, 2011.
7. De Angelis N, Fiordaliso F, Latini R, Calvillo L, Funicello M, Gobbi M, Mennini T, Masson S. Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat. J Mol Cell Cardiol 34: 1655-1665, 2002.
8. Donnelly JD, Gensel JC, Ankeny DP, van Rooijen N, Popovich PG. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods 181: 36-44, 2009.
9. Drobysheva A, Ahmad M, Wang HW, Leenen FH.. Cardiac sympathetic innervation and ubiquitin proteasome system in rats after myocardial infarction. Effects of central MR blockade. Am J Physiol Heart Circ Physiol 305: H1817-H1829, 2013.
10. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
11. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 73: 1907-1916, 2005.
12. Fraccarollo D, Berger S, Galuppo P, Kneitz S, Hein L, Schütz G, Frantz S, Ertl G, Bauersachs J. Deletion of cardiomyocyte mineralo-corticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123: 400-408, 2011.
13. Fraccarollo D, Galuppo P, Schraut S, Kneitz S, van Rooijen N, Ertl G, Bauersachs J. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 51: 905-914, 2008.
14. Francis J, Beltz T, Johnson AK, Felder RB. Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-a in normal rats. Am J Physiol Regul Integr Comp Physiol 285: R1402-R1409, 2003.
15. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281: H2241-H2251, 2001.
16. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31–47, 2002.
17. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 110: 159-173, 2012.
18. Freude B, Masters TN, Kostin S, Robicsek F, Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol 93: 85-89, 1998.
19. Fu YC, Chi CS, Yin SC, Hwang B, Chiu YT, Hsu SL. Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNF a-caspase signaling pathway. Cardiovasc Res 62: 558-567, 2004.
20. Gosain A, Muthu K, Gamelli RL, DiPietro LA. Norepinephrine suppresses wound macrophage phagocytic efficiency through a- and fj-adre-noreceptor dependent pathways. Surgery 142: 170-179, 2007.
21. Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA 108: 1827-1832, 2011.
22. Huang BS, Ahmad M, Tan J, Leenen FH.. Sympathetic hyperactivity and cardiac dysfunction post MI: Different impact of specific CNS versus general AT1 receptor blockade. J Mol Cell Cardiol 43: 479–486, 2007.
23. Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FH.. Central neuronal activation and pressor responses induced by circulating ANG II: Role of brain aldosterone-“ouabain” pathway. Am J Physiol Heart Circ Physiol 299: H422-H430, 2010.
24. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 288: H2491-H2497, 2005.
25. Huang BS, Zheng H, Tan J, Patel KP, Leenen FH. Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone. Exp Physiol 96: 1028-1038, 2011.
26. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763-1774, 2010.
27. Iyonaga K, Takeya M, Yamamoto T, Ando M, Takahashi K. A novel monoclonal antibody, RM-4, specifically recognizes rat macrophages and dendritic cells in formalin-fixed, paraffin-embedded tissues. Histochem J 29: 105-116, 1997.
28. Kaikita K, Hayasaki T, Okuma T, Kuziel WA, Ogawa H, Takeya M. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol 165: 439–447, 2004.
29. Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL. Modulation of macrophage efferocytosis in inflammation. Front Immunol 2: 57, 2011.
30. Lal A, Veinot JP, Ganten D, Leenen FH. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 39: 521-529, 2005.
31. Lal A, Veinot JP, Leenen FH. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 64: 437-447, 2004.
32. Leenen FHH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 101: 221-223, 2007.
33. Lindley TE, Infanger DW, Rishniw M, Zhou Y, Doobay MF, Sharma RV, Davisson RL. Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am J Physiol Regul Integr Comp Physiol 296: R1-R8, 2009.
34. Loan Le TY, Mardini M, Howell VM, Funder JW, Ashton AW, Mihailidou AS. Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Hypertension 59: 1164-1169, 2012.
35. Martinez MM, Reif RD, Pappas D. Detection of apoptosis: A review of conventional and novel techniques. Anal Methods 2: 996-1004, 2010.
36. Nahrendorf M, Swirski FK. Monocyte and macrophage heterogeneity in the heart. Circ Res 112: 1624-1633, 2013.
37. Odörfer KI, Walter I, Kleiter M, Sandgren EP, Erben RG. Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction. J Cell Mol Med 12: 2867-2874, 2008.
38. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280: H2726-H2731, 2001.
39. Rodríguez M, Lucchesi BR, Schaper J. Apoptosis in myocardial infarction. Ann Med 34: 470-479, 2002.
40. Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, Jain M, Amin J, Apstein CS, Colucci WS. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279: H422-H428, 2000.
41. Schwarz K, Simonis G, Yu X, Wiedemann S, Strasser RH. Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction. Mol Cell Biochem 281: 45-54, 2006.
42. Shen Z, Lu M, Duan S, Duan S. Macrophage polarization and inflammation at the interface of cardiovascular disease and metabolism. NA J Med Sci 4 191-195, 2011.
43. Sun J, Li SH, Liu SM, Wu J, Weisel RD, Zhuo YF, Yau TM, Li RK, Fazel SS. Improvement in cardiac function after bone marrow cell therapy is associated with an increase in myocardial inflammation. Am J Physiol Heart Circ Physiol 296: H43-H50, 2009.
44. Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11 (3-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Hypertens Res 30: 427-437, 2007.
45. Takemura G, Ohno M, Hayakawa Y, Misao J, Kanoh M, Ohno A, Uno Y, Minatoguchi S, Fujiwara T, Fujiwara H. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82: 1130–1138, 1998.
46. Troidl C, Mollmann H, Nef H, Masseli F, Voss S, Szardien S, Willmer M, Rolf A, Rixe J, Troidl K, Kostin S, Hamm C, Elsasser A. Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J Cell Mol Med 13: 3485–3496, 2009.
47. Usher MG, Duan S., Ivaschenko CY, Frieler RA, Berger S, Schütz G, Lumeng CN, Mortensen RM. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 120: 3350–3364, 2010.
48. Westcott KV, Huang BS, Leenen FHH. The brain renin angiotensin aldosterone system and ventricular remodeling post myocardial infarction. Can J Physiol Pharmacol 87: 979–980, 2009.
49. Yeung DF, Boom NK, Guo Lee DS H, Schultz SE, Tu JV. Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007. CMAJ 184: E765–E773, 2012.
50. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 294: H1067–H1074, 2008.